ArticleMultiple sclerosis journal - experimental, translational and clinical2021

Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin America.

Ricardo Alonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.